References
Business case for a development program | production of a vaccine against the Covid-19 pandemicPROJECT OUTLINE
- This biotech proposes an ambitious strategy for the development and production of an inactivated and adjuvanted SARS-CoV-2 vaccine.
- It is negotiating with various governments in Europe and across the Atlantic, as well as with international organizations (WHO | COVAX).
- The mastery of the business case is essential to the negotiations of price and financing of the project (clinical development, production capacity, etc.).
- Pagamon builds the business plan and conducts the associated analyses.
PROJECT APPROACH
- Handling of the initial financial model.
- Review of financial and operational assumptions with the program’s stakeholders: pre-clinical and clinical R&D, CAPEX, product development, process, bio-production, filling, packaging, quality control…
- Preparation of scenarios for the Management Committee and the Supervisory Board.
- Analysis of clinical, production and financial risks: yields, success rates, clinical results, payment schedule, etc.
- Construction of a financial model capable of managing multiple successive or parallel contracts as well as various clinical and industrial options.
RESULTS
- Modeling of costs and cash flows for each scenario.
- Supported negotiations with public authorities for their “at risk” national pre-orders of doses.
- Analysis and recommendations for the Management Committee and the Supervisory Board.
- This biotech has signed a contract with the UK government for the supply of 60 million doses for €470 million, with options to supply an additional 130 million doses.
Pagamon is a strategy and transformation consulting firm founded in 2013. We support major players in the industry, services and life sciences sectors in their search for balance. Helping them structure their strategic vision, transform their operational and/or digital model, and drive change. To support profitable, sustainable and responsible growth. As a committed player, Pagamon leads the Observatory of the Balanced Organization™, articulated around a "think tank" and an annual survey. In order to provide an innovative, sometimes offbeat, perspective on the strategic and operational implementation of transformations to support the growth of companies.